Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
56
ERTH.CX Quote, Financials, Valuation and Earnings
Last price:
$0.13
Seasonality move
:
9.75%
Day range:
$0.12 - $0.13
52-week range:
$0.06 - $0.20
Dividend yield:
0%
P/E ratio:
151.77x
P/S ratio:
2.93x
P/B ratio:
2.27x
Volume:
354.2K
Avg. volume:
130.4K
1-year change:
92.31%
Market cap:
$20.1M
Revenue:
$6.9M
EPS (TTM):
-$0.05
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $506.9K | $12.3M | $17.3M | $13.9M | $6.9M | |
| Revenue Growth (YoY) | 177.43% | 2326.63% | 40.42% | -19.41% | -50.43% | |
| Cost of Revenues | $3.3M | $10.2M | $17M | $14.8M | $8.5M | |
| Gross Profit | -$2.8M | $2.1M | $246.5K | -$845.9K | -$1.6M | |
| Gross Profit Margin | -559.68% | 17% | 1.43% | -6.08% | -22.64% | |
| R&D Expenses | $292K | $155.1K | $282.5K | $105.1K | $814.8K | |
| Selling, General & Admin | $326.2K | $4.3M | $3.1M | $2.5M | $2.5M | |
| Other Inc / (Exp) | -$30.7K | -$1.5M | -$4M | $3.2M | -$298.9K | |
| Operating Expenses | $1.1M | $6M | $3.6M | $2.7M | $3.6M | |
| Operating Income | -$3.9M | -$3.9M | -$3.4M | -$3.6M | -$5.2M | |
| Net Interest Expenses | -- | $115.2K | $170.6K | $211.6K | $195.3K | |
| EBT. Incl. Unusual Items | -$3.9M | -$4.6M | -$7.7M | -$523.8K | -$5.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $69.5K | -$650K | -$608K | -$1.1M | |
| Net Income to Company | -$3.9M | -$4.7M | -$7.1M | $84.2K | -$4.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$3.9M | -$4.7M | -$7.1M | $84.2K | -$4.3M | |
| Basic EPS (Cont. Ops) | -$0.08 | -$0.06 | -$0.06 | $0.00 | -$0.03 | |
| Diluted EPS (Cont. Ops) | -$0.08 | -$0.06 | -$0.06 | $0.00 | -$0.03 | |
| Weighted Average Basic Share | $46.7M | $74.6M | $120.1M | $141.9M | $141.9M | |
| Weighted Average Diluted Share | $46.7M | $74.6M | $120.1M | $141.9M | $141.9M | |
| EBITDA | -$3.6M | -$2.7M | -$1.5M | -$1.4M | -$3M | |
| EBIT | -$3.9M | -$3.9M | -$3.4M | -$3.6M | -$5.2M | |
| Revenue (Reported) | $506.9K | $12.3M | $17.3M | $13.9M | $6.9M | |
| Operating Income (Reported) | -$3.9M | -$3.9M | -$3.4M | -$3.6M | -$5.2M | |
| Operating Income (Adjusted) | -$3.9M | -$3.9M | -$3.4M | -$3.6M | -$5.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.3M | $2.7M | $3.6M | $2.1M | $2M | |
| Revenue Growth (YoY) | 1538.14% | 19.23% | 30.45% | -40.09% | -6.91% | |
| Cost of Revenues | $2.4M | $3M | $3.8M | $2.5M | $2.5M | |
| Gross Profit | -$100.2K | -$299.3K | -$200.2K | -$361.8K | -$558.4K | |
| Gross Profit Margin | -4.39% | -10.99% | -5.64% | -17% | -28.19% | |
| R&D Expenses | $78.7K | $39.8K | $21K | $188.3K | $3.2K | |
| Selling, General & Admin | $1.7M | $686.2K | $618.7K | $107K | $604.7K | |
| Other Inc / (Exp) | -$474.5K | $117.7K | $855.5K | $2.7M | -- | |
| Operating Expenses | $1.8M | $1.1M | $853.9K | $751.3K | $635.2K | |
| Operating Income | -$1.9M | -$1.4M | -$1.1M | -$1.1M | -$1.2M | |
| Net Interest Expenses | $18.9K | $29K | $55.9K | $47.7K | $284.2K | |
| EBT. Incl. Unusual Items | -$2.4M | -$1.6M | -$232.7K | $1.5M | -$1.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$500.2K | -$199K | -$249K | -- | |
| Net Income to Company | -$2.4M | -$1.1M | -$33.7K | $1.8M | -$1.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$2.4M | -$1.1M | -$33.7K | $1.8M | -$1.5M | |
| Basic EPS (Cont. Ops) | -$0.03 | -$0.01 | -$0.00 | $0.01 | -$0.01 | |
| Diluted EPS (Cont. Ops) | -$0.03 | -$0.01 | -$0.00 | $0.01 | -$0.01 | |
| Weighted Average Basic Share | $82.4M | $141.3M | $141.9M | $141.9M | $160.4M | |
| Weighted Average Diluted Share | $82.4M | $141.3M | $141.9M | $141.9M | $160.4M | |
| EBITDA | -$1.5M | -$932.4K | -$476.2K | -$562.8K | -$601.2K | |
| EBIT | -$1.9M | -$1.4M | -$1.1M | -$1.1M | -$1.2M | |
| Revenue (Reported) | $2.3M | $2.7M | $3.6M | $2.1M | $2M | |
| Operating Income (Reported) | -$1.9M | -$1.4M | -$1.1M | -$1.1M | -$1.2M | |
| Operating Income (Adjusted) | -$1.9M | -$1.4M | -$1.1M | -$1.1M | -$1.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $4.5M | $20.5M | $14.8M | $7.9M | $6.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $5.8M | $19.2M | $14.6M | $9.5M | $8.1M | |
| Gross Profit | -$1.3M | $1.3M | $209.1K | -$1.6M | -$1.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $206.6K | $188.8K | $786.3K | $66K | |
| Selling, General & Admin | $3.1M | $3.8M | $2.3M | $2M | $3.9M | |
| Other Inc / (Exp) | -$494.3K | -$1.9M | -$2M | $4.2M | -- | |
| Operating Expenses | $3.5M | $4.9M | $2.5M | $3.4M | $2.8M | |
| Operating Income | -$4.7M | -$3.6M | -$2.3M | -$5.1M | -$4.5M | |
| Net Interest Expenses | $53.8K | $182.1K | $198.6K | $199.1K | $678.8K | |
| EBT. Incl. Unusual Items | -$5.2M | -$4.8M | -$4.5M | -$988.9K | -$7.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$670.4K | -$302.1K | -$799K | -$505K | |
| Net Income to Company | -$5.2M | -$4.2M | -$4.2M | -$189.9K | -$7.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$5.2M | -$4.2M | -$4.2M | -$189.9K | -$7.1M | |
| Basic EPS (Cont. Ops) | -$0.08 | -$0.04 | -$0.03 | -$0.00 | -$0.05 | |
| Diluted EPS (Cont. Ops) | -$0.08 | -$0.04 | -$0.03 | -$0.00 | -$0.05 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$3.7M | -$1.8M | -$180.6K | -$2.8M | -$2.3M | |
| EBIT | -$4.7M | -$3.6M | -$2.3M | -$5.1M | -$4.5M | |
| Revenue (Reported) | $4.5M | $20.5M | $14.8M | $7.9M | $6.4M | |
| Operating Income (Reported) | -$4.7M | -$3.6M | -$2.3M | -$5.1M | -$4.5M | |
| Operating Income (Adjusted) | -$4.7M | -$3.6M | -$2.3M | -$5.1M | -$4.5M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $12.8M | $10.3M | $4.3M | $3.9M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $13.3M | $10.9M | $5.6M | $5.3M | -- | |
| Gross Profit | -$484K | -$521.2K | -$1.3M | -$1.5M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $172.3K | $78.6K | $759.9K | $11.1K | -- | |
| Selling, General & Admin | $2.7M | $1.9M | $1.4M | $1.8M | -- | |
| Other Inc / (Exp) | -$597.2K | $1.4M | $2.4M | $11.7K | -- | |
| Operating Expenses | $3.1M | $2M | $2.7M | $1.9M | -- | |
| Operating Income | -$3.6M | -$2.5M | -$4M | -$3.4M | -- | |
| Net Interest Expenses | $128.5K | $159K | $146.5K | $630K | -- | |
| EBT. Incl. Unusual Items | -$4.5M | -$1.3M | -$1.7M | -$4M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$739.9K | -$392K | -$583K | -- | -- | |
| Net Income to Company | -$3.7M | -$861.7K | -$1.1M | -$4M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$3.7M | -$861.7K | -$1.1M | -$4M | -- | |
| Basic EPS (Cont. Ops) | -$0.03 | -$0.01 | -$0.01 | -$0.03 | -- | |
| Diluted EPS (Cont. Ops) | -$0.03 | -$0.01 | -$0.01 | -$0.03 | -- | |
| Weighted Average Basic Share | $337.2M | $425.7M | $425.7M | $459.1M | -- | |
| Weighted Average Diluted Share | $337.2M | $425.7M | $425.7M | $459.1M | -- | |
| EBITDA | -$2.2M | -$897.4K | -$2.4M | -$1.7M | -- | |
| EBIT | -$3.6M | -$2.5M | -$4M | -$3.4M | -- | |
| Revenue (Reported) | $12.8M | $10.3M | $4.3M | $3.9M | -- | |
| Operating Income (Reported) | -$3.6M | -$2.5M | -$4M | -$3.4M | -- | |
| Operating Income (Adjusted) | -$3.6M | -$2.5M | -$4M | -$3.4M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $953.8K | $1.3M | $3.6M | $1M | $119.9K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $3M | $3.8M | $4.3M | $1.6M | |
| Inventory | -- | $926.3K | $11.9M | $5.3M | $4.2M | |
| Prepaid Expenses | $365.9K | -- | $44.4K | $157.6K | $181.5K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.4M | $5.3M | $19.7M | $10.9M | $6.2M | |
| Property Plant And Equipment | $4.2M | $8.8M | $9.3M | $9.9M | $9.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | $1.7M | -- | -- | -- | |
| Other Intangibles | -- | $10.9M | $9.8M | $8.6M | $4.2M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $5.6M | $26.8M | $38.8M | $29.4M | $19.7M | |
| Accounts Payable | $434.9K | $5.2M | $10.9M | $5.2M | $4.3M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | $588.7K | $521.5K | $728.8K | $485.6K | |
| Current Portion Of Capital Lease Obligations | $30K | $65.4K | $129.9K | $230.4K | $262.6K | |
| Other Current Liabilities | -- | $1.9M | $3.4M | -- | -- | |
| Total Current Liabilities | $591.3K | $7.7M | $16.3M | $7M | $5.9M | |
| Long-Term Debt | $363.3K | $434.3K | $3.5M | $2.9M | $2.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $954.6K | $16.3M | $23.9M | $14.1M | $8.5M | |
| Common Stock | $14.5M | $24.2M | $29.9M | $29.9M | $29.9M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $4.7M | $10.5M | $14.9M | $15.3M | $11.2M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $4.7M | $10.5M | $14.9M | $15.3M | $11.2M | |
| Total Liabilities and Equity | $5.6M | $26.8M | $38.8M | $29.4M | $19.7M | |
| Cash and Short Terms | $953.8K | $1.3M | $3.6M | $1M | $119.9K | |
| Total Debt | $393.3K | $499.7K | $4.2M | $3.9M | $3.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $230.7K | $4.4M | $1.7M | $111.1K | $221.6K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.7M | $6.2M | $4.5M | $2.5M | $2.1M | |
| Inventory | $1.1M | $11.6M | $7.2M | $4.2M | $3.6M | |
| Prepaid Expenses | -- | $159.1K | $259.3K | $250.8K | $220.7K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $4.3M | $22.5M | $14.1M | $7.2M | $6.4M | |
| Property Plant And Equipment | $8M | $9.4M | $10.1M | $9.4M | $10.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $2.5M | $1.7M | -- | -- | -- | |
| Other Intangibles | $10.9M | $10.1M | $8.9M | $7.7M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $25.7M | $43.7M | $33.1M | $24.3M | $20.5M | |
| Accounts Payable | $3.7M | $11.1M | $7M | $4M | $4.1M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $417.1K | $727.4K | $818.7K | $681.3K | -- | |
| Current Portion Of Capital Lease Obligations | $118.4K | $106.3K | $223.6K | $266.4K | -- | |
| Other Current Liabilities | $589.7K | $1.4M | -- | -- | -- | |
| Total Current Liabilities | $4.9M | $16M | $9.5M | $6.3M | $9.4M | |
| Long-Term Debt | $3.1M | $3.5M | $3.1M | $2.5M | $2.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $16.8M | $25.4M | $18.8M | $10M | $11.6M | |
| Common Stock | $22.6M | $30.5M | $29.9M | $29.9M | $30.5M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $8.9M | $18.3M | $14.3M | $14.3M | $8.8M | |
| Total Liabilities and Equity | $25.7M | $43.7M | $33.1M | $24.3M | $20.5M | |
| Cash and Short Terms | $230.7K | $4.4M | $1.7M | $111.1K | $221.6K | |
| Total Debt | $3.7M | $4.3M | $4.2M | $3.4M | $6.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.9M | -$4.7M | -$7.1M | $84.2K | -$4.3M | |
| Depreciation & Amoritzation | $301.6K | $1.2M | $1.9M | $2.2M | $2.2M | |
| Stock-Based Compensation | $392.5K | $840.7K | $613.7K | $292.6K | $153K | |
| Change in Accounts Receivable | $50.7K | -$275.8K | -$625.7K | -$180.7K | $2.6M | |
| Change in Inventories | -- | $440.2K | -$11M | $6.6M | $1.1M | |
| Cash From Operations | -$3.8M | -$416.7K | -$6.4M | -$732K | $114.7K | |
| Capital Expenditures | -- | $2M | $2.4M | $1.7M | $447.9K | |
| Cash Acquisitions | -- | $1.5M | -- | -- | -- | |
| Cash From Investing | -- | -$3.8M | -$2.3M | -$1.2M | -$314K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $3M | $889.5K | -- | $250K | |
| Long-Term Debt Repaid | -$64.5K | -$1.7M | -$622.9K | -$650.8K | -$968.4K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$214.6K | -- | -- | -- | -- | |
| Cash From Financing | $4.3M | $4.6M | $11.1M | -$650.8K | -$718.4K | |
| Beginning Cash (CF) | $953.8K | $1.3M | $3.6M | $1M | $119.9K | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $516.9K | $321.2K | $2.4M | -$2.6M | -$917.7K | |
| Ending Cash (CF) | $1.5M | $1.6M | $6M | -$1.6M | -$797.8K | |
| Levered Free Cash Flow | -$3.8M | -$2.4M | -$8.9M | -$2.4M | -$333.2K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$2.4M | -$1.1M | -$33.7K | $1.8M | -$1.5M | |
| Depreciation & Amoritzation | $411.8K | $493.9K | $578K | $550.3K | $592.4K | |
| Stock-Based Compensation | $840.6K | $598.4K | $214.2K | $20K | $27.2K | |
| Change in Accounts Receivable | $32.4K | -$1.5M | -$607.4K | -$278.8K | -$1.1M | |
| Change in Inventories | -$137K | -$7.5M | $573.6K | $1M | $394.4K | |
| Cash From Operations | -$504.6K | -$2.5M | $207.9K | $246.6K | -$393.5K | |
| Capital Expenditures | $714.4K | $581.1K | $229.4K | $61.4K | $236.8K | |
| Cash Acquisitions | $72.1K | -- | -- | -- | -- | |
| Cash From Investing | -$804.9K | -$581.1K | -$229.4K | $23.6K | -$236.8K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $3M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.6M | -$154.5K | -$258.8K | -$176.1K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $1.4M | -$4.5K | -$258.8K | -$176.1K | $411.7K | |
| Beginning Cash (CF) | $230.7K | $4.4M | $1.7M | $111.1K | $221.6K | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $88.5K | -$3.1M | -$280.2K | $94.1K | -$218.5K | |
| Ending Cash (CF) | $319.2K | $1.3M | $1.4M | $205.2K | $3K | |
| Levered Free Cash Flow | -$1.2M | -$3.1M | -$21.5K | $185.2K | -$630.3K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$5.2M | -$4.2M | -$4.2M | -$189.9K | -$7.1M | |
| Depreciation & Amoritzation | $966.2K | $1.8M | $2.1M | $2.2M | $2.2M | |
| Stock-Based Compensation | $845.7K | $598.4K | $250K | $193.7K | $169.3K | |
| Change in Accounts Receivable | $210.1K | -$3.4M | $1.6M | $2.4M | $53.7K | |
| Change in Inventories | -- | -$10.5M | $4.4M | $3M | $598.2K | |
| Cash From Operations | -$2.1M | -$6.3M | $409.1K | -$547.1K | -$1.4M | |
| Capital Expenditures | $1.1M | $1.9M | $3M | $322.7K | $2.4M | |
| Cash Acquisitions | $1.5M | $18.4K | -- | -- | -- | |
| Cash From Investing | -$2.6M | -$2.3M | -$2.5M | -$202.6K | -$2.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $889.5K | -- | $200K | -- | |
| Long-Term Debt Repaid | -$1.7M | -$358.4K | -$650.5K | -$1M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $3.9M | $12.8M | -$650.5K | -$842.3K | $3.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$738.2K | $4.2M | -$2.7M | -$1.6M | $110.5K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$3.2M | -$8.2M | -$2.6M | -$869.8K | -$3.8M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.7M | -$861.7K | -$1.1M | -$4M | -- | |
| Depreciation & Amoritzation | $1.4M | $1.6M | $1.7M | $1.7M | -- | |
| Stock-Based Compensation | $598.4K | $234.6K | $135.8K | $152.2K | -- | |
| Change in Accounts Receivable | -$2.9M | -$681.3K | $1.9M | -$634.1K | -- | |
| Change in Inventories | -$10.7M | $4.7M | $1.1M | $553.5K | -- | |
| Cash From Operations | -$7.3M | -$404.6K | -$219.7K | -$1.8M | -- | |
| Capital Expenditures | $1M | $1.6M | $246.6K | $2.2M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$965.5K | -$1.1M | -$126.6K | -$2.2M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $889.5K | -- | $200K | $1.3M | -- | |
| Long-Term Debt Repaid | -$361.1K | -$388.7K | -$780.3K | -$185.6K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $11.4M | -$388.7K | -$580.3K | $4.1M | -- | |
| Beginning Cash (CF) | $12.7M | $6.1M | $572.1K | $961.7K | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3.2M | -$1.9M | -$926.6K | $101.7K | -- | |
| Ending Cash (CF) | $15.8M | $4.2M | -$354.4K | $1.1M | -- | |
| Levered Free Cash Flow | -$8.3M | -$2M | -$466.3K | -$4M | -- | |
Get ERTH.CX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ERTH.CX
Sector
P/E ratio
151.77x
19.88x
PEG ratio
0.00x
-0.02x
P/B ratio
2.27x
1.85x
Price / LTM sales
2.93x
1.65x
Growth Metrics
ERTH.CX
Sector
Revenue growth
-6.91%
2.4%
Earnings growth
-173.6%
--
Revenue (5-year growth)
106.73%
3.24%
Earnings forecast
--
$0.03
Profitability
ERTH.CX
Sector
Profitability FY 2024
-$1.6M
--
Return on invested capital
-45.73%
-9.18%
Return on assets
-34.06%
-10.59%
Return on equity
-65.23%
-9.79%
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
Feb
10
Estimated Next Earnings Date
May
12
Balance Sheet
ERTH.CX
Sector
Total cash
$221.6K
$2.6M
Short term investments
--
$217K
Total assets
$19.7M
$16.7M
Long term debt
$6.4M
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
67
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
33
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
